Global Hepatitis B diagnostic tests market expected to generate revenue of around USD 1020 million by end of 2024, growing at a CAGR of around 6.5% between 2018 and 2024.
Hepatitis B Diagnostic Tests Market
The report covers forecast and analysis for the hepatitis B diagnostic tests market on a global and regional level. The study provides historical data from 2015 to 2017 along with a forecast from 2018 to 2024 based on revenue (USD Million). The study includes drivers and restraints for the hepatitis B diagnostic tests market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the hepatitis B diagnostic tests market on a global level.
In order to give the users of this report a comprehensive view of the hepatitis B diagnostic tests market, we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein the product type and end-user segments are benchmarked based on their market size, growth rate, and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new technology launch, agreements, partnerships, collaborations & joint ventures, research& development, technology and regional expansion of major participants involved in the market on the global and regional basis. Moreover, the study covers price trend analysis, the product portfolio of various companies according to the region.
The study provides a decisive view of the hepatitis B diagnostic tests market by segmenting the market based on product type, end user, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2018 to 2024. Based on product type, the market is segmented as enzyme immunoassay kits and point-of-care testing kits. The enzyme immunoassay kits segment is further segmented as anti-hepatitis B core antibody test, hepatitis B surface antigen test, and anti-hepatitis B surface antibody test, and the point-of-care testing kits segment is sub-segmented as strips and cassettes/cards. On the basis of the end user, the hepatitis B diagnostic tests market is segmented as hospitals, diagnostic centers, clinics, and home care settings. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa with its further division into major countries including the U.S., Rest of North America, the UK, Germany, France, Italy, Spain, Rest of Europe, China, Japan, India, Southeast Asia, Rest of Asia Pacific, Brazil, Rest of Latin America, GCC Countries, South Africa, and Rest of the Middle East and Africa. This segmentation includes demand for hepatitis B diagnostic tests market based on individual product type and end-user in all the regions and countries.
The report also includes detailed profiles of end players such as Bio-Rad Laboratories, Inc., bioMérieux SA, Abbott Laboratories, Biogate Laboratories Ltd., DiaSorin S.p.A., Vista Diagnostics International, Meridian Bioscience, Inc., J.Mitra & Co. Ltd., General Biologicals Corporation, and Siemens Medical Solutions USA, Inc.
This report segments the global Hepatitis B Diagnostic Tests market as follows:
Global Hepatitis B Diagnostic Tests Market: Product Type Segment Analysis
Global Hepatitis B Diagnostic Tests Market: End-User Segment Analysis
Global Hepatitis B Diagnostic Tests Market: Regional Segment Analysis